IFAM
CBAY

Institutional & Family Asset Management’s Cymabay Therapeutics CBAY Stock Holding History

Institutional & Family Asset Management’s Portfolio CBAY Stock Details CBAY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-89
Closed – – 904
2019
Q3 		$0 Sell
89
-1
-1% -$6 ﹤0.01% 895
2019
Q2 		$1K Hold
90
– – ﹤0.01% 824
2019
Q1 		$1K Hold
90
– – ﹤0.01% 819
2018
Q4 		$1K Hold
90
– – ﹤0.01% 800
2018
Q3 		$1K Buy
+90
New +$1.12K ﹤0.01% 826

Other funds holding CBAY

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
ECM
Engine Capital Management New York $1.03B AUM 4.33% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.49B AUM 208.7% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
FCMI
Foresite Capital Management IV Larkspur, California $290M AUM 143.88% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

Institutional & Family Asset Management's CBAY Position: Q4 2019 in Review

Institutional & Family Asset Management sold out of Cymabay Therapeutics (CBAY) in Q4 2019, closing a stake of 89 shares.

Institutional & Family Asset Management first reported a position in CBAY in Q3 2018 and held it in 5 quarters. The position peaked at $1K in Q2 2019. 113 funds tracked by Wall St. Rank hold CBAY as of Q4 2019.

  • Institutional & Family Asset Management reported no remaining Cymabay Therapeutics position as of Q4 2019 after selling out during the quarter.
  • Institutional & Family Asset Management sold 89 Cymabay Therapeutics shares in Q4 2019.
  • Institutional & Family Asset Management first reported a position in Cymabay Therapeutics in Q3 2018 and held it in 5 quarters.
  • Institutional & Family Asset Management's Cymabay Therapeutics position peaked at $1K in Q2 2019.
  • 113 funds tracked by Wall St. Rank held Cymabay Therapeutics as of Q4 2019.

Based on Institutional & Family Asset Management's 13F filing for Q4 2019, filed 14 Feb 2020.